Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex for treatment-naïve diabetic macular edema (EYEberia)
NCT03953807Phase 4Completed
- Sponsor
- Allergan
- Start
- Sep 2019
- Primary completion
- Jul 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Allergan. Started Sep 2019; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03953807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03953807.